Fig. 3From: Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanomaKaplan-Meier estimates illustrating differences in clinical outcome stratified by KIRREL expression. a Recurrence free survival in the entire cohort. b Melanoma specific survival in the entire cohort. c Recurrence free survival in thin melanomas only. d Melanoma specific survival in thin melanomas onlyBack to article page